We have established strong and lasting relationships with our clients. Here are some things they had to say about us.
"What began as a collaboration for a single IMPD in 2017 has evolved into a comprehensive partnership supporting five of our development programs. Over the past eight years, the Venn CMC team has consistently demonstrated a unique blend of technical expertise and strategic insight. They have provided critical support across the full spectrum of our CMC needs, including process and formulation development, CDMO selection and management, authoring key regulatory documentation for both IND and IMPD sections, GMP audits, and due diligence support for out-licensing. Venn’s reliability and deep technical knowledge are key to our success, and we value their team as a highly professional and effective partner."
Dr. Takayuki Irie, Ph.D.
Principal Scientist, Carna Biosciences Inc., Japan
“Want to send a thanks to my friends at Venn Life Sciences. After I reached out to the Linked community asking for help to a European regulatory hurdle, they gave their time and found the solution allowing our study in a rare disease to progress. Very grateful.”
"We have been delighted with the work produced by the Venn Life Sciences team to date. We have been working with them closely since the inception of Poolbeg Pharma and their team has been instrumental in guiding our clinical and pre-clinical programs. We look forward to further collaborations with Venn on future projects.”
“Working with Venn has been a great experience. The Venn team is collaborative, responsive and flexible and produce work to a very high standard. They have generously accommodated a shifting timeline in our drug development programme due to unexpected events. I highly recommend working with Venn Life Sciences.”
"The Drug development plan that was created with Venn was a critical success factor for obtaining funding from investors. I am also pleased to see that the plan that was developed 7 years ago remains spot on in the current clinical stage of VarmX."
“We truly appreciate the strong and dedicated CMC and CMC-Regulatory Affairs collaboration with Venn Life Sciences. Over the past 7 years, their support has extended beyond these areas to include non-clinical and clinical topics. This excellent collaboration has been instrumental in the successful submission of our dossier to the FDA.”
